索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 研究圣经
  • 中国知网(CNKI)
  • 西马戈
  • 乌尔里希的期刊目录
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-WorldCat
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 米亚尔
  • 科学索引服务 (SIS)
  • 欧洲酒吧
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Legal and Ethical Aspects of Wireless Health

Atalla K, Chaudhary A, Eshaghian-Wilner MM, Gupta A, Mehta R, Nayak A, Ravicz K, Shiroma B and Trivedi P

Nanomedicine is a revolutionary field with the potential to vastly improve healthcare worldwide. Despite these benefits, the revolutionary rather than evolutionary nature of these new medicines raises unforeseen problems relating to ethics, privacy, intellectual property, and regulatory law. Ethical issues include the risks posed to users of a drug during the research and development stage, unequal distribution of new medicines, and the possibility for genetic self-enhancement. Privacy issues involve laws that do not adequately protect people’s privacy and the possibility for genetic discrimination based on increasingly accessible genetic information. Intellectual property issues are primarily concerned with the balance between protecting nanomedicine-related intellectual property rights and the desire to encourage future innovation. Nanomedicine is particularly difficult to protect from an intellectual property perspective due to bureaucratic distinctions, difficult analysis against prior art, and the complexity of the technology itself. However, the industry as well as the courts may not be enough to properly regulate this nascent field. Given the remarkable potential of nanomedicine to improve global healthcare as well as the great risks that come with new developments in the field, it is important for researchers, industry, legislatures, and the public to work together to ensure the impending medical revolution keeps people safe and changes our lives for the better.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证